Umb Bank, N.A. Beam Therapeutics Inc. Transaction History

Umb Bank, N.A.

$6.61 Billion
Q3 2025

A detailed history of Umb Bank, N.A. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 100 shares of BEAM stock, worth $2,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Holding current value

$2,202

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 04, 2025	BUY	$16.01 - $25.1 $1,601 - $2,510	100 New	100 $2,000
Q4 2021 Feb 09, 2022	BUY	$68.02 - $99.06 $3,537 - $5,151	52 New	52 $4,000

Others Institutions Holding BEAM

# of Institutions

254

Shares Held

95.1M

Call Options Held

888K

Put Options Held

549K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11M
Shares

$243 Million
1.88% of portfolio
Farallon Capital Management LLC San Francisco, CA

10.1M
Shares

$222 Million
1.06% of portfolio
Vanguard Group Inc Valley Forge, PA

9.25M
Shares

$204 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$168 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

4.83M
Shares

$106 Million
1.27% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account